Lichenoid type cutaneous hyperpigmentation induced by nebivolol


Creative Commons License

Aslan A. N. , Guney M. C. , AKÇAY M., KELEŞ T., BOZKURT E.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, cilt.45, ss.268-270, 2017 (ESCI İndekslerine Giren Dergi)

  • Cilt numarası: 45 Konu: 3
  • Basım Tarihi: 2017
  • Doi Numarası: 10.5543/tkda.2016.02151
  • Dergi Adı: TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
  • Sayfa Sayısı: ss.268-270

Özet

Cutaneous hyperpigmentation is a common and well-defined side effect of many drugs, such as nonsteroidal anti-inflammatory drugs, beta-blockers, and tetracyclines, but to the best of our knowledge there is no case of skin discoloration related to nebivolol in the literature. Presently described is lichenoid type cutaneous hyperpigmentation in a 46-year-old female patient. Hyperpigmentation emerged 3 months after initiating use of nebivolol and resolved after cessation of drug use. It was concluded that effect emerged as result of therapeutic doses of nebivolol.